Moderna Inc

MRNA

NASDAQ. Currency in USD

189.89 -3.40 ( -1.76% )

Real time prices: December 19

Market Cap.
72.95B
Beta (5Y monthly)
1.73
Price/Earnings
6.42
EPS (TTM)
27.64
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
6.90M
1y Target Est.
209.47
Day's Range
187.86
-
204.00
52 Week's Range
115.03
-
217.25

Historical Summary

Performance
EPS growth
Share Buybacks

About Moderna Inc

Sector
Healthcare
Industry
Biotechnology
Website
https://www.modernatx.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
405.45M
Employees
3700
Address
200 Technology Square, Cambridge, MA, United States, 02139
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Latest news

Why This Moderna Analyst Is Turning Bullish On Drugmaker's Pipeline
Why This Moderna Analyst Is Turning Bullish On Drugmaker's Pipeline

Shares of Moderna Inc (NASDAQ: MRNA) rallied in premarket trading on Monday. While the COVID-19...
By Benzinga - 6 weeks ago

Moderna's (MRNA) BA.1 Omicron Booster Gets CHMP Nod for Kids
Moderna's (MRNA) BA.1 Omicron Booster Gets CHMP Nod for Kids

The CHMP recommends authorizing Moderna's (MRNA) bivalent COVID-19 booster vaccine, targeting the Omicron BA.1 subvariant,...
By Zacks Investment Research - 6 weeks ago

Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022

Upgrades For NRG Energy Inc (NYSE:NRG), B of A Securities upgraded the previous rating of...
By Benzinga - 6 weeks ago

What's Going On With Moderna Stock Monday?
What's Going On With Moderna Stock Monday?

Moderna Inc (NASDAQ: MRNA) shares are trading higher Monday following positive analyst coverage from Jefferies....
By Benzinga - 6 weeks ago

Stock Market News for Dec 19, 2022
Stock Market News for Dec 19, 2022

U.S. stock markets closed sharply lower On Friday as market participants remained concerned about a...
By Zacks Investment Research - 6 weeks ago

Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday
Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday

Morgan Stanley cut VTEX (NYSE: VTEX) price target from $7 to $5.  Morgan Stanley analyst...
By Benzinga - 6 weeks ago

Wall Street Breakfast: Elon Gone?
Wall Street Breakfast: Elon Gone?

Listen on the go! A daily podcast of Wall Street Breakfast will be available by...
By Seeking Alpha - 6 weeks ago

Why Shares Of COVID-19 Vaccine Maker Moderna Are Shooting Higher On Monday
Why Shares Of COVID-19 Vaccine Maker Moderna Are Shooting Higher On Monday

Shares of coronavirus vaccine maker Moderna Inc. (NASDAQ: MRNA) were rallying in premarket trading on...
By Benzinga - 6 weeks ago